Cellectis S.A.CLLSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
5Y CAGR+75.2%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+75.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
16.5x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 183.87% |
| Q2 2025 | 32.39% |
| Q1 2025 | -32.76% |
| Q4 2024 | 0.83% |
| Q3 2024 | 37.43% |
| Q2 2024 | 17.63% |
| Q1 2024 | 29.36% |
| Q4 2023 | -43.09% |
| Q3 2023 | 12.63% |
| Q2 2023 | -0.97% |
| Q1 2023 | -282.78% |
| Q4 2022 | 146.87% |
| Q3 2022 | -0.15% |
| Q2 2022 | 6.55% |
| Q1 2022 | 5.48% |
| Q4 2021 | 27.02% |
| Q3 2021 | -13.04% |
| Q2 2021 | -88.28% |
| Q1 2021 | 47.85% |
| Q4 2020 | -30.05% |
| Q3 2020 | 11.13% |
| Q2 2020 | -329.19% |
| Q1 2020 | 137.32% |
| Q4 2019 | -44.89% |
| Q3 2019 | 24.13% |
| Q2 2019 | -51.94% |
| Q1 2019 | 21.00% |
| Q4 2018 | -1.25% |
| Q3 2018 | -33.22% |
| Q2 2018 | 12.87% |
| Q1 2018 | 10.30% |
| Q4 2017 | -8.01% |
| Q3 2017 | -24.55% |
| Q2 2017 | -4.13% |
| Q1 2017 | -0.04% |
| Q4 2016 | -52.81% |
| Q3 2016 | -16.33% |
| Q2 2016 | 51.82% |
| Q1 2016 | -1852.78% |
| Q4 2015 | 108.72% |